| PERIOD ENDING | 31-Mar-08 | 31-Mar-07 | 31-Mar-06 | | Total Revenue | 28,468,280 | 23,580,729 | 22,799,103 | | Cost of Revenue | 16,927,580 | 13,884,211 | 13,622,257 | | | Gross Profit | 11,540,700 | 9,696,518 | 9,176,846 | | | Operating Expenses | | Research Development | 1,875,890 | 1,500,034 | 1,556,872 | | Selling General and Administrative | 7,591,390 | 6,441,034 | 6,282,547 | | Non Recurring |
-
| 797,297 | 735,410 | | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 2,073,420 | 958,153 | 602,017 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (6,200) | (29,212) | 111,667 | | Earnings Before Interest And Taxes | 2,067,220 | 928,941 | 713,684 | | Interest Expense | 73,800 | 53,822 | 33,214 | | Income Before Tax | 1,993,420 | 875,119 | 680,470 | | Income Tax Expense | 821,430 | 504,518 | 299,350 | | Minority Interest | (154,740) | (107,144) | (109,274) | | | | Net Income From Continuing Ops | 1,044,310 | 291,915 | 316,376 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 1,044,310 | 291,915 | 316,376 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $1,044,310 | $291,915 | $316,376 |
|
0.01% Nasdaq 
Income Statement
